Cargando…
Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application
Ischemic stroke is one of the leading causes of human death and disability worldwide. So far, ultra-early thrombolytic therapy is the most effective treatment. However, most patients still live with varying degrees of neurological dysfunction due to its narrow therapeutic time window. It has been co...
Autores principales: | Liao, Shaohua, Luo, Chunxia, Cao, Bingzhen, Hu, Huaiqiang, Wang, Suxia, Yue, Huili, Chen, Lin, Zhou, Zhenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576438/ https://www.ncbi.nlm.nih.gov/pubmed/28900446 http://dx.doi.org/10.1155/2017/2193432 |
Ejemplares similares
-
The Updated Role of Transcranial Ultrasound Neuromodulation in Ischemic Stroke: From Clinical and Basic Research
por: Zhu, Shuiping, et al.
Publicado: (2022) -
Endothelial progenitor cells in acute ischemic stroke
por: Martí-Fàbregas, Joan, et al.
Publicado: (2013) -
Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
por: Liao, Shaohua, et al.
Publicado: (2017) -
Corrigendum: Clinical Characteristics and Predictors of Outcome for Onconeural Antibody-Associated Disorders: A Retrospective Analysis
por: Liao, Shaohua, et al.
Publicado: (2018) -
Anti-neuron antibody syndrome: clinical features, cytokines/chemokines and predictors
por: Liao, Shaohua, et al.
Publicado: (2021)